Novo Nordisk said Wednesday that Wegovy is the first Health Canada-approved treatment for both chronic weight management and to reduce the risk of non-fatal myocardial infarction. The treatment ...
or history of myocardial infarction or stroke]); and (3) secondary prevention of cardiovascular disease (CVD; aged 45 years or older, BMI ≥27 kg/m 2, and a history of myocardial infarction or ...
"This on-treatment analysis has to be considered ... that most of the patients in this trial had an ST elevation myocardial infarction (STEMI) with very little left ventricular dysfunction or ...